The latest from DTC Perspectives
Fair Balance or Scare Balance
Friday, 21 November 2008, 08:23 AM
The Wall Street Journal's Melinda Beck wrote a fascinating column (11/18) on the power of suggestion. Titled “When Drug Labels Make You Sick”, Ms. Beck explores the little studied issue of how reading the litany of side effects actually can make you more prone to disease. The FDA is rightly concerned with informing consumers of the risks they take when beginning use of an Rx drug. All of us are entitled to know if the drugs we are prescribed can kill us or cause debilitating side effects. read more
Rep. Henry Waxman wins battle
Thursday, 20 November 2008, 02:28 PM
In a shift that portends more difficulty for pharmaceutical marketers next year, Rep. Henry Waxman (D-Calif.) was elected today by House Democrats as the next chairman of the House's Energy and Commerce Committee, the important Congressional committee that has oversight of the Food and Drug Administration. read more
The DTC Ad Fall Off
Friday, 14 November 2008, 08:14 AM
Ad Age ran a projection of DTC spending in 2008 using the first 8 months of TNS data. Writer Rich Thomaselli says 2008 may be down 9% based on the projection. That would put the DTC spending back to 2005 levels and under $5 billion. Ok I will not quibble with the Ad Age estimate. I think it will be slightly better because the networks and local media will be offering some incredible deals on ad rates. The numerous ad declines from auto, tech, travel, and retail will lead to some opportunistic spending by pharma. I'll call the year down 6-8%. read more
2009 DTC National Conference - Call for Speakers
Wednesday, 12 November 2008, 04:09 PM
DTC Perspectives is seeking presenters of new insights and/or innovations in consumer prescription drug marketing practices to participate at the 2009 DTC National Conference (April 15-17, in Washington, D.C.). To be considered for this unique presentation opportunity to an audience of DTC marketing leaders, please submit your proposal by close of business Friday, Nov. 21. read more
President Obama
Friday, 07 November 2008, 08:36 AM
Congratulations to Senator Obama. It is an exciting moment whenever we have a new administration, particularly in this time of fear and pessimism. For those of us who work in the drug industry “change” will be both good and bad. First, let's get to the good part. It is likely we will evolve to greater insurance coverage of our population in the next few years. That means more potential users of pharmaceutical products. We also can expect fewer people to go bankrupt because of illness. That is a good thing for society. read more
Health Care Bubble: The Sequel
Friday, 24 October 2008, 09:03 AM
I am considered a Pfizer retiree. I worked there for about three days after their takeover of Warner-Lambert in 2000. I am covered for health insurance by the Pfizer retiree plan. When I received the retiree newsletter last week I was rather shocked to see that insurance costs will rise dramatically starting in 2009. Apparently Pfizer and many other corporations have capped their contributions which reached a peak in 2008. So all retirees are going to carry the up charges from now on. read more
The New Realities 2009
Friday, 17 October 2008, 08:28 AM
As we approach an election with a seemingly forgone conclusion of an Obama victory, it is time to take stock of some new realities. Some are good for our industry, others may be bad. They are realities, however, and we all need to deal with them. read more
The Health Bubble
Friday, 10 October 2008, 07:41 AM
Dr. Bernadine Healy, health columnist for U.S. News and World Report, wrote a thought provoking column this week. It was titled, “Is Healthcare Armageddon Next? “ Dr Healy feels that with healthcare costs rising so fast, it is unsustainable. It is only a matter of time before the bubble bursts on a personal and government level. read more
EU's Pharmaceutical Forum to Relax Advertising Restrictions
Tuesday, 07 October 2008, 01:57 PM
After a three-year long process, the Pharmaceutical Forum in the European Union concluded last week with an important decision on patient information programs sponsored by pharmaceutical companies. Co-chairs Gunter Verheugen, vice president of the European Commission, and Commissioner Androulla Vassiliou both agreed that recommendations by the Forum will benefit patients, healthcare budgets and pharmaceutical innovations. read more
Main Street and DTC
Friday, 03 October 2008, 08:09 AM
It looks increasingly likely we will have a Democratic victory in November. That means Mr. Obama and an increased majority in Congress. The drug industry has donated to both candidates in fairly equal amounts indicating their lack of a clear preference and a hedge in their bets. The traditional Republican leaning of drug companies is absent this election because Mr. McCain has a record of criticizing the drug industry as greedy. read more
DTC and You
Register for the DTC National Conference
The DTC National Conference
will be held in Washington DC on April 15-17, 2009.
Don't miss the forum for DTC Thought Leaders.
FREE Subscription to our Magazine
Start a free subscription now to the industry's leading
publication focused soley on DTC marketing,
DTC Perspectives Magazine is published quarterly.
Subscribe to DTC Insights
The DTC Marketer's Executive Brief - DTC INSIGHTS
takes all the information and data pertinent to DTC
and analyzes it for a busy pharma marketer.
Subscribe to Bob Ehrlich’s newsletter
A weekly blog column from DTCPI CEO Bob Ehrlich
that reflects his observations on key trends affecting
our industry
| ABOUT SSL CERTIFICATES |
